🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This was a 28-week, open-label, multicenter, single-group Phase 2 explorato...
Status
Completed
Location
Travere Investigational Site
Start Date
2023-05-19
Trial ID
NCT05856760
Treatments Being Tested
To evaluate the safety, efficacy and tolerability of sparsentan oral suspen...
Status
Recruiting
Location
Cedars-Sinai Medical Center
Start Date
2021-08-12
Trial ID
NCT05003986
Treatments Being Tested
This single-center, open-label, randomized, single and multiple-dose, 3-way...
Status
Completed
Location
Travere Investigational Site
Start Date
2020-06-18
Trial ID
NCT05562362
Treatments Being Tested
To determine the long-term nephroprotective potential of treatment with spa...
Status
Completed
Location
Travere Investigational Site
Start Date
2018-04-17
Trial ID
NCT03493685
Treatments Being Tested
This study will investigate whether RE-021 (Sparsentan), a selective dual-a...
Status
Completed
Location
Balboa Nephrology Medical Group
Start Date
2014-03
Trial ID
NCT01613118
Treatments Being Tested
To determine the nephroprotective potential of treatment with sparsentan in...
Status
Recruiting
Location
Cambridge University Hospitals NHS Trust
Start Date
2020-12-10
Trial ID
NCT04663204
Treatments Being Tested
To determine the long-term (approximately 2 years) nephroprotective potenti...
Status
Active Not Recruiting
Location
Travere Investigational Site
Start Date
2018-12-11
Trial ID
NCT03762850
Treatments Being Tested